CIRIN Finishes 2007-08 on High Notes:

CIRIN finishes financial year 2007-08 with 45% growth over last year in sales revenue. This growth rate is up from 23% registered in 2006-07 and 13% in 2005-06.

IMS places CIRIN in third group (based on turnover) of top tier (based on sustained growth rate) pharmaceutical firms operating in Pakistan. Management is hopeful of shifting to second group in top tier by the end of 2009 (i.e. amongst companies with turnover between Rs. 500Million - Rs. 1Biliion).

CIRIN Registers Growth Rate of 43.8% in 2008: Q1 (IMS News Flash)

In the recent IMS News Flash for 2008: Q1, CIRIN is said to register phenominal growth rate of 43.8% in first quarter of 2008, and 32.7% on twelve months basis (2007). Growth rate in the quarter is third best amongst Top60 Pharma Companies whereas, annual growth rate is sixth best.

The company also overtook five of its immediate competitors in one go - a distinction in itself. At this pace, CIRIN is sure to climb more places in ongoing quarter.

This high growth rate in sales of company's products is an evidence of perception of CIRIN brand in the eyes of customer and is a just reward for the untiring effort of the entire TeamCIRIN.